Microbiological data for patients with febrile neutropenia

Clinical Infectious Diseases

Volumn 39, Issue SUPPL. 1, 2004, Pages

  Kanamaru, Akihisa ^a   Tatsumi, Youichi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; APLASTIC ANEMIA; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; CANDIDA; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; CONTROLLED STUDY; ENTEROCOCCUS; FEBRILE NEUTROPENIA; FEMALE; FUNGEMIA; GRAM NEGATIVE BACTERIUM; HEMATOLOGIC DISEASE; HEMATOLOGY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; T CELL LEUKEMIA; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; DRUG RESISTANCE, MICROBIAL; FEMALE; FEVER; FUNGEMIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; JAPAN; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS;

EID: 3242748085     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383042     Document Type: Conference Paper

References (13)

1. Schimpff SC, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284:1061-5.
2. Cometta A, Zinner S, deBock R, et al. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1995; 39:445-52.
3. Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1996; 40:1108-15.
4. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, et al. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996; 15:291-6.
5. Richard P, Del Valle GA, Moreau P, et al. Viridans streptococcal bacteremia in patients with neutropenia. Lancet 1995; 345:1607-9.
6. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-7.
7. Cruciani M, Rampazzo R, Malena M, et al. Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. Clin Infect Dis 1996; 23:795-805.
8. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 1998; 16: 1179-87.
9. Zinner SH. Changing epidemiology of infections in patients with neutropenia and cancer, emphasis on gram-positive and resistant bacteria. Clin Infect Dis 1999; 29:490-4.
10. Jones RN. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia. Clin Infect Dis 1999; 29:495-502.
11. Diekema DJ, Jones RN, Rolston KV. Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers. Diagn Microbiol Infect Dis 1999; 34:37-43.
12. Matsuhisa A, Saito Y, Ueyama H, et al. Detection of bacteria phagocyte-smears from septicemia-suspected blood by in situ hybridization using biotinylated probes. Microbiol Immunol 1994; 38:511-7.
13. Shimada J, Masaoka T, Ueda Y, et al. Clinical trial of in situ hybridization method for the rapid diagnosis of sepsis. J Infect Chemother 1999; 5:21-31.